2026 Sentinel lymph node biopsy utilization and positivity in veterans with cutaneous melanoma: A comparative analysis of the VA Cancer Registry and the SEER Program. Daniel Y. Kim, Susan M. Swetter, Linden Huhmann, Jacqueline M. Ferguson, Kimberly Breglio, Allyson C. Spence, Lee Wheless, Mary T. Brophy, Nhan V. Do, Nathanael Fillmore‡, Rebecca I. Hartman‡‡ Equal senior authorship Journal of the American Academy of Dermatology U.S. Veterans and VA Data Cutaneous Melanoma VA Cancer Registry SEER Database Sentinel Lymph Node Biopsy
2025 Area Deprivation Index and Melanoma Thickness in Veterans. Alejandra K. Moncayo, Jacqueline M. Ferguson, Mathew P. Dizon, Linden Huhmann, Daniel Y. Kim, Nhan Do, Mary T. Brophy, Thomas F. Osborne, Allyson C. Spence, Nathanael R. Fillmore, Susan M. Swetter‡, Rebecca I. Hartman‡‡ Equal senior authorship JAMA Dermatology161(6), 582-588 U.S. Veterans and VA Data Electronic Health Records Cutaneous Melanoma Health Disparities Area Deprivation Index
2024 Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among veteran patients with cutaneous melanoma. Daniel Y. Kim, Susan M. Swetter, Linden Huhmann, Matthew P. Dizon, Jacqueline M. Ferguson, Thomas F. Osborne, Allyson C. Spence, Amina Ziad, Nathanael Fillmore‡, Rebecca I. Hartman‡‡ Equal senior authorship Journal of the American Academy of Dermatology90(3), 620-623 U.S. Veterans and VA Data Retrospective Cohort Study Cutaneous Melanoma Immune Checkpoint Inhibitors BRAF/MEK Inhibitors
